GlucoTrack (NASDAQ:GCTK) versus FitLife Brands (NASDAQ:FTLF) Head to Head Review

GlucoTrack (NASDAQ:GCTK) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, institutional ownership, earnings, valuation and profitability.

Profitability

This table compares GlucoTrack and FitLife Brands’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
GlucoTrack	N/A	-324.84%	-178.16%
FitLife Brands	7.77%	19.75%	9.57%

Earnings and Valuation

This table compares GlucoTrack and FitLife Brands”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
GlucoTrack	N/A	N/A	-$19.39 million	($55.51)	-0.01
FitLife Brands	$81.46 million	1.10	$6.33 million	$0.63	15.13

FitLife Brands has higher revenue and earnings than GlucoTrack. GlucoTrack is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

GlucoTrack has a beta of 0.78, meaning that its stock price is 22% less volatile than the S&P 500. Comparatively, FitLife Brands has a beta of -0.01, meaning that its stock price is 101% less volatile than the S&P 500.

Analyst Ratings

This is a summary of recent recommendations for GlucoTrack and FitLife Brands, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
GlucoTrack	1	0	0	0	1.00
FitLife Brands	1	1	2	0	2.25

FitLife Brands has a consensus target price of $21.50, suggesting a potential upside of 125.60%. Given FitLife Brands’ stronger consensus rating and higher probable upside, analysts plainly believe FitLife Brands is more favorable than GlucoTrack.

Institutional and Insider Ownership

10.9% of GlucoTrack shares are held by institutional investors. Comparatively, 2.3% of FitLife Brands shares are held by institutional investors. 2.2% of GlucoTrack shares are held by insiders. Comparatively, 61.4% of FitLife Brands shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

FitLife Brands beats GlucoTrack on 11 of the 13 factors compared between the two stocks.

About GlucoTrack

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

About FitLife Brands

FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; sports nutrition products; weight loss and sports nutrition products; sports nutrition and general wellness formulations with an emphasis on natural, vegan, and organic ingredients; and male health and weight loss products, as well as other diet, health, and sports nutrition supplements and related products; and value-oriented sports nutrition and weight loss products. It offers MRC products which includes general health supplements; and natural skincare and beauty products. In addition, it markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, and Maritime Naturals through franchised stores, as well as through retail locations, which include specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.